Biomedical Engineering Reference
In-Depth Information
Camacho N, Landsman V, Stremersch S (2010) The connected patient. In: Wuyts S, Dekimpe M,
Gijsbrechts E, Pieters FGMR (eds) The connected customer: the changing nature of consumer
and business markets. Routledge Academic, London
Campbell S (2011) Potential effects of a ban on direct-to-consumer advertising of new prescription
drugs. Congressional budget offi ce issue brief. Congressional Budget Offi ce, Washington, DC
Cantor J (2010) Does direct to consumer advertising of antidepressants affect visits to physicians?
Cornell University, Ithaca, NY
Chen Y (2011) Consumer learning and product diffusion—the case of ED drug. Princeton
University, Princeton, NJ
Chesnes M, Jin GZ (2011) Direct-to-consumer advertising and online search. Working paper.
https://editorialexpress.com/cgi-bin/conference/download.cgi?db_name=IIOC2011&paper_id=
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG (2004) Effects of pharmaceutical
promotion on adherence to the treatment guidelines for depression. Med Care
42(Dec):1176-1185
Donohue JM, Cevasco M, Rosenthal MB (2007) A decade of direct-to-consumer advertising of
prescription drugs. N Engl J Med 357:673-681
Fischer M, Albers S (2010) Patient- or physician-oriented marketing: what drives primary demand
for prescription drugs? J Mark Res XLVII(Feb):19
Frank RG, Salkever DS (1997) Generic entry and the pricing of pharmaceuticals. J Econ Manag
Strategy 6(1):75-90
Frank RG, Berndt ER, Donohue JM, Epstein A, Rosenthal M (2002) Trends in direct-to-consumer
advertising of prescription drugs. Kaiser Family Foundation report.
Gönül FF, Carter F, Wind J (2000) What kind of patients and physicians value direct-to-consumer
advertising of prescription drugs. Health Care Manag Sci 3:215-226
Herzenstein M, Misra S, Posavac SS (2004) How consumers' attitude toward direct-to-consumer
advertising of prescription drugs infl uence ad effectiveness, and consumer and physician
behavior. Mark Lett 15(4):201-212
Hosken D, Wendling B (2010) Informing the uninformed: how drug advertising affects check-up
visits. Int J Ind Organ (forthcoming)
Iizuka T (2004) What explains the use of direct-to-consumer advertising of prescription drugs?
J Ind Econ LII:349-379
Iizuka T, Jin GZ (2005) The effect of prescription drug advertising on doctor visits. J Econ Manag
Strategy 14:701-727
Iizuka T, Jin GZ (2007) Direct to consumer advertising and prescription choice. J Ind Econ 55:771
Kolsarici C, Vakratsas D (2010) Category versus brand-level advertising messages in a highly
regulated environment. J Marketing Res 47(6):1078-1089
Kremer STM, Bijmolt THA, Leefl ang PSH, Wieringa JE (2008) Generalizations on the effective-
ness of pharmaceutical promotional expenditures. Int J Res Mark 25(4):234-246
Liang BA, Mackey T (2011a) Direct-to-consumer advertising with interactive internet media:
global regulation and public health issues. J Am Med Assoc 305(8):824-825
Liang BA, Mackey T (2011b) Prevalence and global health implications of social media in direct-
to-consumer drug advertising. J Med Internet Res 13(3)
Liu Q, Gupta S (2011) The impact of direct-to-consumer advertising of prescription drugs on
physician visits and drug requests: empirical fi ndings and public policy implications. Int J Res
Mark 28:205-217
Mintzes B (2006) What are the public health implications? Direct-to-consumer advertising of
prescription drugs in Canada. Health Council of Canada, Toronto
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion
SA (2002) Infl uence of direct to consumer pharmaceutical advertising and patients' request on
prescribing decisions: two site cross sectional survey. Br Med J 324(Feb 2):278-279
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion
SA (2003) How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in
primary care environments with and without legal DTCA. Can Med Assoc J 169(5):405-412
Search WWH ::
Custom Search